Angiogenic factor with G-patch and FHA domains 1 pseudogene 2 (AGGF1P2)

Angiogenic factor with G-patch and FHA domains 1 pseudogene 2 (AGGF1P2) is a processed pseudogene, meaning it is a DNA segment with high sequence similarity to the functional AGGF1 gene but rendered nonfunctional due to mutations or interruptions in its coding sequence. Processed pseudogenes arise from retrotransposition events and lack protein-coding capacity, typically being transcriptionally inactive, although some pseudogenes are transcribed as non-coding RNAs[2][4][5]. AGGF1P2 does not encode a receptor, enzyme, or other canonical therapeutic target, and there are currently no specific functions, disease associations, or drugs relevant to AGGF1P2. Key context: - AGGF1 is a functional gene involved in angiogenesis but AGGF1P2 is a nonfunctional pseudogene copy. - Pseudogenes broadly may sometimes play regulatory roles via their transcripts (such as acting as miRNA decoys), but there is no evidence or publication indicating AGGF1P2 has any such activity or relevance[2][4]. - AGGF1P2 is listed in gene databases as a processed pseudogene with accession HGNC:38052 and Ensembl ENSG00000233435[5]. - This entry would not normally be considered in therapeutic target databases or pharmacological genomics resources. In summary, AGGF1P2 is not a protein-coding gene or recognized therapeutic target but a nonfunctional genomic element classified as a processed pseudogene.